Takeaway

• A fixed-dose combination of 180 μg albuterol and 160 μg budesonide on an as-needed basis cuts the risk for severe asthma exacerbation by 26% vs albuterol alone in patients with uncontrolled moderate-to-severe asthma receiving a wide range of inhaled glucocorticoid-containing maintenance therapies.

Why this matters

• Patients frequently rely on albuterol...